Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score
2021 · Journal of Hepatology · 286 citations
https://doi.org/10.1016/j.jhep.2021.09.035
K
Katharina Pomej
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
2.1K
Citations
16
h-index
18
i10-index
Katharina Pomej is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Liver Disease and Transplantation & Liver Disease Diagnosis and Treatment. The author has an h-index of 16, co-authored 63 publications.
ORCID: 0000-0002-2807-3565Papers by this author
worksClinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma—a European multicenter cohort
2023 · ESMO Open · 16 citations
https://doi.org/10.1016/j.esmoop.2023.100783
TOP-488-YI Fecal microbiota transplant combined with atezolizumab plus bevacizumab in patients with hepatocellular carcinoma who progressed on atezolizumab plus bevacizumab-interim analysis of the FAB-HCC phase II pilot study
2024 · Journal of Hepatology · 1 citations
https://doi.org/10.1016/s0168-8278(24)01376-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat